Bleakley Financial Group, LLC

Position in MRK — Merck & Co., Inc.

CIK 1936953 PARSIPPANY, NJ

Position in MRK

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$20,032,893

+$4,489,381 QoQ

Shares Held

155,898

+20.6% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.51%

of 13F equity value

Holder Rank

#520

of 3,769 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bleakley Financial Group, LLC holds $192,517,114 across 15 Drug Manufacturers - General names. MRK ranks #4 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	45,004	$53,979,152
2	JNJ	Johnson & Johnson	142,327	$36,146,788
3	ABBV	AbbVie Inc.	92,109	$23,178,308
4	MRK	Merck & Co., Inc. This page	155,898	$20,032,893
5	AMGN	Amgen Inc	38,445	$13,921,703
6	AZN	Astrazeneca PLC	66,437	$12,597,783
7	NVS	Novartis AG	44,930	$7,041,429
8	SNY	Sanofi	159,361	$6,798,340

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$20,032,893	155,898	+20.6%	Shares	Sole	2026-08-05
2026-03-31	$15,543,512	129,217	+2.3%	Shares	Sole	2026-05-04
2025-12-31	$13,292,969	126,287	+76.8%	Shares	Sole	2026-02-09
2025-09-30	$5,996,546	71,447	+2.5%	Shares	Sole	2025-11-10
2025-06-30	$5,518,639	69,715	-4.4%	Shares	Sole	2025-07-30
2025-03-31	$6,545,388	72,921	-11.6%	Shares	Sole	2025-05-01
2024-12-31	$8,205,707	82,486	+0.9%	Shares	Sole	2025-01-27
2024-09-30	$9,279,441	81,714	-50.5%	Shares	Sole	2024-10-16
2024-06-30	$20,429,476	165,020	+97.5%	Shares	Sole	2024-08-12
2024-03-31	$11,022,575	83,536	+3.8%	Shares	Sole	2024-05-08
2023-12-31	$8,776,110	80,500	+0.2%	Shares	Sole	2024-01-25
2023-09-30	$8,274,915	80,378	-49.5%	Shares	Sole	2023-11-14
2023-06-30	$18,362,818	159,137	-10.2%	Shares	Sole	2023-08-14
2023-03-31	$18,853,371	177,210	+3.3%	Shares	Sole	2023-05-12
2022-12-31	$19,037,244	171,584	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.